Koji Oba

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. ncbi request reprint The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data
    Satoshi Morita
    Health and Community Medicine Program, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Psychooncology 17:474-9. 2008
  2. ncbi request reprint Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer
    Koji Oba
    Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto 606 8501, Japan
    Cancer Immunol Immunother 56:905-11. 2007
  3. doi request reprint Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis
    Koji Oba
    EBM Research Center, Kyoto University Graduate School of Medicine, Yoshidakonoe cho, Sakyo ku, Kyoto, 606 8501, Japan
    Int J Clin Oncol 14:85-9. 2009
  4. ncbi request reprint Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer
    Koji Oba
    EBM Research Center, Kyoto University Graduate School of Medicine, Yoshidakonoe cho, Kyoto, Japan
    Anticancer Res 29:2739-45. 2009
  5. ncbi request reprint Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan
    K Oba
    Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto, Japan
    J Chemother 18:311-7. 2006
  6. doi request reprint Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial
    Kazuwa Nakao
    Department of Medicine and Medical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Hypertens Res 33:600-6. 2010
  7. doi request reprint Long-term effects of candesartan and amlodipine on cardiovascular mortality and morbidity in Japanese high-risk hypertensive patients: rationale, design, and characteristics of candesartan antihypertensive survival evaluation in Japan extension (CASE-J Ex
    Kenji Ueshima
    EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Contemp Clin Trials 30:97-101. 2009
  8. ncbi request reprint Influence of coronary risk factors on coronary events in Japanese high-risk hypertensive patients. - Primary and secondary prevention of ischemic heart disease in a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) tria
    Kenji Ueshima
    EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Circ J 75:2411-6. 2011
  9. pmc Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial
    Shinji Yasuno
    EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Diabetes Care 33:1122-7. 2010
  10. doi request reprint Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial
    Shinji Yasuno
    EBM Research Center, Kyoto University Graduate School of Medicine, Yoshida Konoecho, Sakyo ku, Kyoto 606 8501, Japan
    J Hypertens 27:1705-12. 2009

Detail Information

Publications19

  1. ncbi request reprint The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data
    Satoshi Morita
    Health and Community Medicine Program, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Psychooncology 17:474-9. 2008
    ..Extensive discussions with the EORTC Group are needed from both cross-cultural and clinical perspectives in order to establish a consensus on the various language versions of the QLQ-STO22...
  2. ncbi request reprint Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer
    Koji Oba
    Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto 606 8501, Japan
    Cancer Immunol Immunother 56:905-11. 2007
    ..7; P = 0.16]. The results of this meta-analysis suggest that adjuvant immunochemotherapy with PSK improves the survival of patients after curative gastric cancer resection...
  3. doi request reprint Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis
    Koji Oba
    EBM Research Center, Kyoto University Graduate School of Medicine, Yoshidakonoe cho, Sakyo ku, Kyoto, 606 8501, Japan
    Int J Clin Oncol 14:85-9. 2009
    ..It is expected to determine and quantify the role of adjuvant chemotherapy in detail from the GASTRIC...
  4. ncbi request reprint Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer
    Koji Oba
    EBM Research Center, Kyoto University Graduate School of Medicine, Yoshidakonoe cho, Kyoto, Japan
    Anticancer Res 29:2739-45. 2009
    ..In the present study, the effect of immunochemotherapy with lentinan compared with that of chemotherapy alone was evaluated in patients with advanced gastric cancer through individual patient data (IPD) meta-analysis...
  5. ncbi request reprint Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan
    K Oba
    Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto, Japan
    J Chemother 18:311-7. 2006
    ..73 (95%CI=0.60-0.89). Our findings show that in Japan adjuvant chemotherapy using o-FP for long-term maintenance therapy appears to be effective for gastric cancer patients after curative resection...
  6. doi request reprint Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial
    Kazuwa Nakao
    Department of Medicine and Medical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Hypertens Res 33:600-6. 2010
    ..Candesartan treatment may suppress all-cause death and reduce the incidence of new-onset diabetes in patients with obesity...
  7. doi request reprint Long-term effects of candesartan and amlodipine on cardiovascular mortality and morbidity in Japanese high-risk hypertensive patients: rationale, design, and characteristics of candesartan antihypertensive survival evaluation in Japan extension (CASE-J Ex
    Kenji Ueshima
    EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Contemp Clin Trials 30:97-101. 2009
    ..CASE-J Ex will clarify the long-term effects of ARB and CCB on CV mortality and morbidity. Additionally, because the number of diabetic patients is increased, the evidences from CASE-J Ex will be valuable...
  8. ncbi request reprint Influence of coronary risk factors on coronary events in Japanese high-risk hypertensive patients. - Primary and secondary prevention of ischemic heart disease in a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) tria
    Kenji Ueshima
    EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Circ J 75:2411-6. 2011
    ..The aim of the present subanalysis was to evaluate the influence of coronary risk factors on coronary events in these patients as an observational study irrespective of allocated drugs...
  9. pmc Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial
    Shinji Yasuno
    EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Diabetes Care 33:1122-7. 2010
    ..Here, we examined the association between pulse pressure and the risk of new-onset diabetes in high-risk Japanese hypertensive patients...
  10. doi request reprint Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial
    Shinji Yasuno
    EBM Research Center, Kyoto University Graduate School of Medicine, Yoshida Konoecho, Sakyo ku, Kyoto 606 8501, Japan
    J Hypertens 27:1705-12. 2009
    ....
  11. ncbi request reprint Impact of left ventricular hypertrophy on the time-course of renal function in hypertensive patients – a subanalysis of the CASE-J trial –
    Kenji Ueshima
    EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Circ J 74:2132-8. 2010
    ..In this subanalysis of the CASE-J, which was conducted to compare the effects of candesartan and amlodipine in Japanese high-risk hypertensive patients, THE ASSOCIATION OF LEFT VENTRICULAR HYPERTROPHY (LVH) WITH RENAL FUNCTION IS CLARIFIED...
  12. ncbi request reprint Efficacy of oral anticancer agents for colorectal cancer
    Junichi Sakamoto
    Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Dis Colon Rectum 49:S82-91. 2006
  13. ncbi request reprint Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials
    Junichi Sakamoto
    Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Yoshidakonoe cho, Sakyo ku, Kyoto, 606 8501, Japan
    Cancer Immunol Immunother 55:404-11. 2006
    ..72 (95% CI: 0.58-0.90; P=0.003). The results of this meta-analysis suggest that adjuvant immunochemotherapy with PSK can improve both survival and disease-free survival of patients with curatively resected colorectal cancer...
  14. doi request reprint Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms
    Yusuke Okuyama
    Department of Gastroenterology, Kyoto First Red Cross Hospital, Honmachi 15 749, Higashiyama ku, Kyoto, Japan
    Jpn J Clin Oncol 41:477-82. 2011
    ....
  15. pmc Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran
    Saman Zamani
    Department of Global Health and Socio Epidemiology, Kyoto University School of Public Health, Kyoto, Japan
    J Urban Health 87:603-16. 2010
    ..These study findings provide a behavioral profile of prisoners in regard to drug-related harm and can be considered in any plan to introduce or improve provision of MMT in prisons in Iran or other countries with similar features...
  16. ncbi request reprint Effects of cardiac complications on cardiovascular events in Japanese high-risk hypertensive patients: subanalysis of the CASE-J trial
    Kenji Ueshima
    EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Circ J 73:1080-5. 2009
    ..The present study aimed to clarify the effect of cardiac complications on cardiovascular events in patients enrolled in CASE-J...
  17. ncbi request reprint A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer
    Michiya Kobayashi
    Department of Tumor Surgery, Kochi Medical School, Kohasu, Japan
    Gastric Cancer 9:114-9. 2006
    ..We investigated the safety of and compliance with sequential chemotherapy consisting of paclitaxel and S-1, both of which are effective in the treatment of peritoneal dissemination...
  18. doi request reprint A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study group
    Haruhiko Cho
    Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1 1 2, Nakao, Asahi ku, Yokohama 2410815, Japan
    Jpn J Clin Oncol 38:71-3. 2008
    ..The sample size is 86 (43 for surgery alone and 43 for exercise group) to select promising treatment for Phase III trial in a randomized Phase II setting...
  19. ncbi request reprint Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan
    Michiya Kobayashi
    Department of Human Health and Medical Sciences, Kochi Medical School, Oko cho, Nankoku, 783 8505, Japan
    Gastric Cancer 10:52-7. 2007
    ..We aimed to clarify the relationship between the maximum tolerated dose and plasma concentration of paclitaxel in Japanese patients with gastric cancer on a weekly paclitaxel administration regimen...